These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 33284684)

  • 21. Clinical significance of the serum IgM and IgG to SARS-CoV-2 in coronavirus disease-2019.
    Wu LX; Wang H; Gou D; Fu G; Wang J; Guo BQ
    J Clin Lab Anal; 2021 Jan; 35(1):e23649. PubMed ID: 33184940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Nov; 5(6):1324-1336. PubMed ID: 32766840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
    Zhang G; Nie S; Zhang Z; Zhang Z
    J Infect Dis; 2020 Jun; 222(2):183-188. PubMed ID: 32358956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Acute Respiratory Syndrome Coronavirus 2 among Asymptomatic Workers Screened for Work Resumption, China.
    Han X; Wei X; Alwalid O; Cao Y; Li Y; Wang L; Shi H
    Emerg Infect Dis; 2020 Sep; 26(9):2265-7. PubMed ID: 32553070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.
    Li Y; Yao L; Li J; Chen L; Song Y; Cai Z; Yang C
    J Med Virol; 2020 Jul; 92(7):903-908. PubMed ID: 32219885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
    Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of IgG and IgM antibody response in COVID-19 patients.
    Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
    Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.
    Zheng Y; Xu H; Yang M; Zeng Y; Chen H; Liu R; Li Q; Zhang N; Wang D
    J Clin Virol; 2020 Jun; 127():104366. PubMed ID: 32302954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
    Tuaillon E; Bolloré K; Pisoni A; Debiesse S; Renault C; Marie S; Groc S; Niels C; Pansu N; Dupuy AM; Morquin D; Foulongne V; Bourdin A; Le Moing V; Van de Perre P
    J Infect; 2020 Aug; 81(2):e39-e45. PubMed ID: 32504735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
    Chen Y; Ke Y; Liu X; Wang Z; Jia R; Liu W; Yang C; Jia L; Wang Y; Han L; Xia X; Zhang S; Wang C
    J Med Virol; 2021 May; 93(5):2782-2789. PubMed ID: 33085103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.
    He Y; Luo J; Yang J; Song J; Wei L; Ma W
    Front Cell Infect Microbiol; 2020; 10():445. PubMed ID: 32850506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.
    Chen Y; Chen L; Deng Q; Zhang G; Wu K; Ni L; Yang Y; Liu B; Wang W; Wei C; Yang J; Ye G; Cheng Z
    J Med Virol; 2020 Jul; 92(7):833-840. PubMed ID: 32243607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients.
    Pflüger LS; Bannasch JH; Brehm TT; Pfefferle S; Hoffmann A; Nörz D; van der Meirschen M; Kluge S; Haddad M; Pischke S; Hiller J; Addo MM; Lohse AW; Schulze Zur Wiesch J; Peine S; Aepfelbacher M; Lütgehetmann M
    J Clin Virol; 2020 Sep; 130():104549. PubMed ID: 32763809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.